CS logo
small CS logo
Armes Family Cancer Center

Findlay, Ohio, United States
Cancer treatment center in Hancock County, Ohio
15990 Medical Dr S, Findlay, OH 45840

About Armes Family Cancer Center


"We understand how cancer touches lives because it's touched ours. We're here to help & we're dedicated to providing access to that help. We're your neighbors & friends and part of your community. The Virginia B. Gardner Healing Garden located outside the building has been constructed in full view of patients receiving infusion therapy and is accessible for patients, families and visitors."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Armes Family Cancer Center


During the past decade, Armes Family Cancer Center conducted 127 clinical trials. In the 10-year time frame, 127 clinical trials started and 36 clinical trials were completed, i.e. on average, 28.3% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 35 clinical trials were completed. i.e. 61.4% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Armes Family Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 61 trials, followed by "SWOG Cancer Research Network" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Armes Family Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 80 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator and "Biologics, Inc." with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 29 trials.

Clinical Trials Conditions at Armes Family Cancer Center


According to Clinical.Site data, the most researched conditions in "Armes Family Cancer Center" are "Stage IV Lung Cancer AJCC v8" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials). Many other conditions were trialed in "Armes Family Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Armes Family Cancer Center


Most popular intervention types in "Armes Family Cancer Center" are "Drug" (115 trials), "Other" (80 trials), "Biological" (57 trials), "Procedure" (39 trials) and "Radiation" (14 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (35 trials), "Laboratory Biomarker Analysis" (32 trials), "Computed Tomography" (24 trials), "Biospecimen Collection" (23 trials) and "Questionnaire Administration" (23 trials). Other intervention names were less common.

Clinical Trials Genders at Armes Family Cancer Center


The vast majority of trials in "Armes Family Cancer Center" are 119 trials for "All" genders, 16 trials for "Female" genders and 8 trials for "Male" genders.

Clinical Trials Status at Armes Family Cancer Center


Currently, there are NaN active trials in "Armes Family Cancer Center". undefined are not yet recruiting, 55 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Armes Family Cancer Center, 3 suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Armes Family Cancer Center, 2 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".